Paper One: Annotated Bibliography

Dylan T. Gough

dylangough@mycwi.cc

English 201 002W

Professor Leslie Jewkes

February 12, 2013

Annotated Bibliography

Cohen, Jay S. "Respected physicians call for end of conflicts of interest with the drug industry." The Medical Professions Culture of Corruption. Medicationsense.com, n.d. Web. 7 Feb. 2013. <http://www.medicationsense.com/articles/jan_apr_06/conflict_of_interest_020306.html>.  Dr. Jay S. Cohen examines the conflict of interest present with the pharmaceutical companies and physicians. This source states that there has been an intense effort to influence doctors and sell more drugs. Dr. Cohen realizes and states that the large part of the problem with the drug industry is the physicians who support it and their behaviors regarding patient treatment and prescription. Drug companies to market to doctors spend $19 billion annually. This source deals with the relationship between the drug industry and doctors. This source is important to my research because it shows that the pharmaceutical industry and doctors have a conflict of interest. This is important in my research because the pharmaceutical industry is trying to sell more drugs for a bigger profit. Also, doctors are rewarded by the pharmaceutical industry by how much they can promote these drugs.

Mercola, Dr. Joseph. The FDA exposed. Mercola.com, n.d. Web. 7 Feb. 2013. http://www.mercola.com/Downloads/bonus/the-FDA-exposed/default.aspx

            I thought this source written by Dr. Joseph Mercola was important because it talks about the FDA. This is relative to the pharmaceutical industry because the FDA must approve a drug before it is distributed to the market. It states that is more beneficial for the pharmaceutical companies to have more unhealthy people because that means more sales. This source states that even some of the FDA’s own scientists have doubts about the agency’s credibility. This source deals with the relationship between the FDA and the pharmaceutical industry. This source is very important because it takes about the FDA, something worth mentioning in my research paper because every drug on the market must be approved by the FDA. This will help me in my research because the FDA controls what goes on to the market and what does not.

Ramshaw, Emily. "Payments to Doctors by Pharmaceutical Companies Raise Issues of Conflicts." Texas Tribune 9 June 2012: 1. Web. 7 Feb. 2013. <http://www.nytimes.com/2011/11/25/us/payments-to-doctors-by-pharmaceutical-companies-raise-issues-of-conflicts.html?_r=0>.

            This source written by the Ney York Times goes a little bit more in depth with the conflict of interest between pharmaceutical companies and doctors. It states that many doctors supplement their income from the pharmaceutical companies. It states that drug companies pay medical professionals from speaking engagements, and consulting. It states that the interests of patients may be compromised due to that conflict of interest between the drug companies and physicians. From 2009 to early 2011, at least 25,000 Texas physicians and researchers received a combined $57 million — and probably far more — in cash payments, research money, free meals, travel and other perks, according to data culled from 12 drug companies. Payments also were not being disclosed. Therefore, a federal law has been set in place to discourage and require disclosure of payments. This source will aid me in my research because it goes in a lot of depth about the relationship between the drug industry and doctors. Also, how doctors translate to patients.

"Trade, foreign policy, diplomacy and health." Pharmaceutical Industry . World Health Organization, n.d. Web. 13 Feb. 2013. <http://www.who.int/trade/glossary/story073/en/index.html>.

            This source examines the pharmaceutical industry as a whole.  It deals with the pharmaceutical industry and how they struggle to maintain sales. It states that expenditure on medicines accounts for a major proportion of health costs in developing countries. Therefore, access to treatment is dependent upon the affordability of medicines. It also looks at generic drugs, which is a pharmaceutical product usually intended to be interchangeable with an innovator product that is manufactured without a license from the innovator company and marketed after the expiry date of the patent or other exclusive rights. Generic drugs tend to be cheaper than brand name drugs. The are as effective as brand name drugs as well. I found this post to be good to use in my research because it really focuses in on generic drugs, which are important in the pharmaceutical industry and something important to write about.

"The Pharmaceutical Industry." Boldrine & Levine: Against Intellectual Monopoly. UCLA, n.d. Web. 14 Feb. 2013. <http://levine.sscnet.ucla.edu/papers/ip.ch.9.m1004.pdf>.

            This source is very lengthy, and it was published by UCLA. This source is one of the major ones I will use in my research because it talks about everything that deals with the pharmaceutical industry. I believe his source will help me more then all the other ones because it scope is broad, and the information within is accurate. It talks about the patents that the pharmaceutical industry has. It takes about the various companies within the drug industry. It talks about the history of pharmaceutical patents. This post mostly deals with the patent process of a drug. I found this source to be a good one because it is written by professors at UCLA, and the information in it is very analytical and appropriate to the topic I am researching.